{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T10:46:21Z","timestamp":1767091581126,"version":"3.41.2"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010822","name":"Chengdu Science and Technology Bureau","doi-asserted-by":"publisher","award":["2019-YF05-01242-SN"],"award-info":[{"award-number":["2019-YF05-01242-SN"]}],"id":[{"id":"10.13039\/501100010822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Monoclonal gammopathies of clinical significance (MGCS)-associated myopathy is a group of muscular MGCS-based rare manifestations. It mainly includes amyloid light chain (AL) amyloidosis and sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance. When myopathy manifests as the initial or sole clinical symptom, it can often be delayed or misdiagnosed as other myopathies. We report the case of a 60-year-old man who initially presented with fatigue and muscle weakness of the symmetric proximal lower limbs. Muscle biopsy did not reveal mononuclear cell infiltration, atrophy, necrosis, or positive Congo red staining results. The results of serum protein electrophoresis and immunofixation electrophoresis were negative. No specific diagnosis was established. After 1 year, the patient was diagnosed with AL amyloidosis after myocardial and fat pad biopsies were performed and myopathy was diagnosed as AL amyloidosis-associated myopathy after reassessment. The patient received CyBorD regime chemotherapy and achieved hematological and organ remission. Therefore, we reviewed the clinical and pathological manifestations of MGCS-associated myopathies. Based on published articles and the present case, we conclude that comprehensive screening for MGCS in unexplained myopathy is essential to avoid misdiagnosis or delayed diagnosis.<\/jats:p>","DOI":"10.3389\/fonc.2022.914379","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T05:02:02Z","timestamp":1657774922000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Case Report: Monoclonal Gammopathies of Clinical Significance-Associated Myopathy: A Case-Based Review"],"prefix":"10.3389","volume":"12","author":[{"given":"Hongbin","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Du","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000122","article-title":"Monoclonal Gammopathies of Clinical Significance","volume":"2020","author":"Dispenzieri","year":"2020","journal-title":"Hematology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","article-title":"Systemic Immunoglobulin Light Chain Amyloidosis","volume":"4","author":"Merlini","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.06.027","article-title":"Systemic Immunoglobulin Light Chain Amyloidosis\u2013Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome","volume":"91","author":"Muchtar","year":"2016","journal-title":"Mayo Clinic Proc"},{"key":"B4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/mus.27150","article-title":"Neuromuscular Amyloidosis: Unmasking the Master of Disguise","volume":"64","author":"Pinto","year":"2021","journal-title":"Muscle Nerve"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/art.40320","article-title":"European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13448","article-title":"Characterization of Isolated Amyloid Myopathy","volume":"24","author":"Liewluck","year":"2017","journal-title":"Eur J Neurology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"bcr2016216548","DOI":"10.1136\/bcr-2016-216548","article-title":"Peritoneal Amyloidosis With Myopathy in Primary Systemic (AL) Amyloidosis","volume":"2017","author":"Al-Adhami","year":"2017","journal-title":"BMJ Case Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12882-021-02272-7","article-title":"Monoclonal Gammopathy of Renal Significance (MGRS)-Related AL Amyloidosis Complicated by Amyloid Myopathy: A Case Report","volume":"22","author":"Ono","year":"2021","journal-title":"BMC Nephrology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200108)44:8<1954::AID-ART333>3.0.CO;2-S","article-title":"A Deceptive Case of Amyloid Myopathy: Clinical and Magnetic Resonance Imaging Features","volume":"44","author":"Hull","year":"2001","journal-title":"Arthritis Rheumatism"},{"key":"B10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/jnnp.68.3.385","article-title":"Myopathy Due to Primary Systemic Amyloidosis","volume":"68","author":"Aggarwal","year":"2000","journal-title":"J Neurology Neurosurg &amp; Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.60.6.655","article-title":"Myopathy in Primary Systemic Amyloidosis","volume":"60","author":"Gertz","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4081\/ni.2009.e7","article-title":"Amyloid Myopathy: A Diagnostic Challenge","volume":"1","author":"Tuomaala","year":"2009","journal-title":"Neurol Int"},{"key":"B13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13023-017-0640-2","article-title":"Sporadic Late-Onset Nemaline Myopathy: Clinico-Pathological Characteristics and Review of 76 Cases","volume":"12","author":"Schnitzler","year":"2017","journal-title":"Orphanet J Rare Diseases"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.1.132","article-title":"Adult-Onset Nemaline Myopathy and Monoclonal Gammopathy","volume":"63","author":"Keller","year":"2006","journal-title":"Arch Neurology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4914(01)02089-5","article-title":"Clinical and Genetic Heterogeneity in Nemaline Myopathy \u2013 a Disease of Skeletal Muscle Thin Filaments","volume":"7","author":"Sanoudou","year":"2001","journal-title":"Trends Mol Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000477","article-title":"Sporadic Late-Onset Nemaline Myopathy With Monoclonal Gammopathy of Undetermined Significance","volume":"30","author":"Uruha","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12962","article-title":"Inflammatory Features in Sporadic Late-Onset Nemaline Myopathy are Independent From Monoclonal Gammopathy","volume":"31","author":"Tanboon","year":"2021","journal-title":"Brain Pathology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"9225","DOI":"10.4081\/ejtm.2020.9225","article-title":"Sporadic Late Onset Nemaline Myopathy With Monoclonal Gammopathy of Undetermined Significance: Two Cases With Long Term Stability","volume":"30","author":"Truffert","year":"2020","journal-title":"Eur J Transl Myol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000046585.81304.BC","article-title":"Clinical Course Correlates Poorly With Muscle Pathology in Nemaline Myopathy","volume":"60","author":"Ryan","year":"2003","journal-title":"Neurology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e3181d892c6","article-title":"In Vitro Analysis of Rod Composition and Actin Dynamics in Inherited Myopathies","volume":"69","author":"Vandebrouck","year":"2010","journal-title":"J Neuropathology Exp Neurology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000310813.79325.32","article-title":"Stem Cell Transplantation in a Patient With Late-Onset Nemaline Myopathy and Gammopathy","volume":"71","author":"Benveniste","year":"2008","journal-title":"Neurology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21504","article-title":"Sporadic Late Onset Nemaline Myopathy Responsive to IVIg and Immunotherapy","volume":"41","author":"Milone","year":"2010","journal-title":"Muscle Nerve"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007777","article-title":"Sporadic Late-Onset Nemaline Myopathy: Clinical Spectrum, Survival, and Treatment Outcomes","volume":"93","author":"Naddaf","year":"2019","journal-title":"Neurology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-8741-y","article-title":"Sporadic Late-Onset Nemaline Myopathy: Clinical, Pathology and Imaging Findings in a Single Center Cohort","volume":"265","author":"Monforte","year":"2018","journal-title":"J Neurology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.cn-000893","article-title":"Two Cases of Sporadic Late Onset Nemaline Myopathy Effectively Treated With Immunotherapy","volume":"56","author":"Mizuno","year":"2016","journal-title":"Rinsho Shinkeigaku"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000180362.90078.dc","article-title":"Sporadic Late Onset Nemaline Myopathy","volume":"65","author":"Chahin","year":"2005","journal-title":"Neurology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-017-0080-6","article-title":"Chemotherapy With Stem Cell Transplantation is More Effective Than Immunotherapy in Sporadic Late Onset Nemaline Myopathy With Monoclonal Gammopathy","volume":"53","author":"Kotchetkov","year":"2018","journal-title":"Bone Marrow Transplantation"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-123817","article-title":"Sporadic Late Onset Nemaline Myopathy With a Monoclonal Gammopathy: Comparative Effectiveness of Immuno- and Chemotherapy","volume":"134","author":"Susman","year":"2019","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33483","article-title":"Chemotherapy-Based Approach is the Preferred Treatment for Sporadic Late-Onset Nemaline Myopathy With a Monoclonal Protein","volume":"148","author":"Kotchetkov","year":"2021","journal-title":"Int J Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33571","article-title":"Reply to: Comments on: Chemotherapy-Based Approach is the Preferred Treatment for Sporadic Late-Onset Nemaline Myopathy With a Monoclonal Protein","volume":"149","author":"Kotchetkov","year":"2021","journal-title":"Int J Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.9.1413","article-title":"Inflammatory Myopathy in POEMS Syndrome","volume":"55","author":"Goebels","year":"2000","journal-title":"Neurology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/qjmed\/hcx197","article-title":"Necrotizing Autoimmune Myopathy Associated With POEMS Syndrome Report","volume":"111","author":"Gremain","year":"2017","journal-title":"QJM: Int J Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24545","article-title":"Sporadic Late-Onset Nemaline Myopathy in a Woman With Multiple Myeloma Successfully Treated With Lenalidomide\/Dexamethasone","volume":"51","author":"Montagnese","year":"2015","journal-title":"Muscle Nerve"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.9290","article-title":"Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment Approach","volume":"29","author":"Blad\u00e9","year":"2011","journal-title":"J Clin Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-020-03514-9","article-title":"Diffuse Skeletal Muscle Extramedullary Plasmacytomas: A Rare Case and Review of the Literature","volume":"49","author":"Moore","year":"2020","journal-title":"Skeletal Radiology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"808474","DOI":"10.1155\/2010\/808474","article-title":"IgD Multiple Myeloma Paraproteinemia as a Cause of Myositis","volume":"2010","author":"Colombo","year":"2010","journal-title":"Neurol Res Int"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.12890\/2020_002095","article-title":"Skeletal Myopathy as the Initial Manifestation of Light Chain Multiple Myeloma","volume":"7","author":"Belkhribchia","year":"2020","journal-title":"Eur J Case Rep Intern Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.08.006","article-title":"A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing","volume":"94","author":"Muchtar","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group Guidelines for Serum-Free Light Chain Analysis in Multiple Myeloma and Related Disorders","volume":"23","author":"Dispenzieri","year":"2009","journal-title":"Leukemia"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1309\/LYWM47K2L8XYFFB3","article-title":"Quantitative Analysis of Serum Free Light Chains. A New Marker for the Diagnostic Evaluation of Primary Systemic Amyloidosis","volume":"119","author":"Abraham","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41408-020-0291-8","article-title":"Blood Mass Spectrometry Detects Residual Disease Better Than Standard Techniques in Light-Chain Amyloidosis","volume":"10","author":"Dispenzieri","year":"2020","journal-title":"Blood Cancer J"},{"key":"B42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41408-019-0180-1","article-title":"A Novel Mass Spectrometry Method to Identify the Serum Monoclonal Light Chain Component in Systemic Light Chain Amyloidosis","volume":"9","author":"Sharpley","year":"2019","journal-title":"Blood Cancer J"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.914379\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T05:02:05Z","timestamp":1657774925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.914379\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":42,"alternative-id":["10.3389\/fonc.2022.914379"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.914379","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"article-number":"914379"}}